Skye Bioscience, Inc. Common Stock, Capital Shares Reserved for Future Issuance
Skye Bioscience, Inc. (SKYE) had Common Stock, Capital Shares Reserved for Future Issuance of 15.20 million shares as of 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Notes › Stockholders' Equity Note
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-03-10
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 15.20M shares.
- 2024-12-31: Common Stock, Capital Shares Reserved for Future Issuance 16.02M shares.
- 2023-12-31: Common Stock, Capital Shares Reserved for Future Issuance 6.20M shares.
- 2022-12-31: Common Stock, Capital Shares Reserved for Future Issuance 1.27M shares; Common Stock, Capital Shares Reserved for Future Issuance as first filed 289.73M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance | Common Stock, Capital Shares Reserved for Future Issuance as first filed |
|---|---|---|
| 2025-12-31 | 15.20M shares 10-K · filed 2026-03-10 | |
| 2024-12-31 | 16.02M shares 10-K · filed 2026-03-10 | |
| 2023-12-31 | 6.20M shares 10-K · filed 2025-03-20 | |
| 2022-12-31 | 1.27M shares 10-K · filed 2024-03-22 | 289.73M shares 10-K · filed 2023-03-31 |
| 2021-12-31 | 213.54M shares 10-K · filed 2023-03-31 | |
| 2020-12-31 | 197.48M shares 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |